Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
  • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
  • A61F5/0013—Implantable devices or invasive measures
  • A61F5/0036—Intragastrical devices
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
  • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
  • A61F5/0013—Implantable devices or invasive measures
  • A61F5/003—Implantable devices or invasive measures inflatable

Definitions

• the present invention relates to the technical field of intragastric balloons, used in particular in the treatment of obesity.
• An intragastric balloon is generally in the form of a flexible envelope, airtight and liquid food or physiological.
• the flexible envelope is further equipped with an inflation valve intended to allow, after placement of the balloon in the stomach of a patient, the injection of an inflation fluid, such as air or saline.
• US Pat. No. 5,084,061 for example describes a balloon comprising an inflation valve formed by a channel closed by a succession of two split membranes and opening out of a tubular silicone cone acting as a valve.
• the intragastric balloon comprising such inflatable valves has the disadvantage of being difficult to inflate, given the complexity of the maneuver introduction of an inflation device into the valve, while the balloon is located at the same time. inside the patient's stomach.
• intragastric balloons which are pre-equipped with an inflation device whose needle is completely inserted into the valve. inflation, so as to be in fluid communication with the interior of the balloon envelope.
• the needle is then introduced into the valve well before the placement of the balloon in the stomach of a patient, more precisely, at the end of assembly of the inflation device and the balloon before delivery of the latter to its place of residence.
• the subject of the invention is a set of intragastric treatment as defined in claim 1.
• the implementation of an inflator needle receiving channel advantageously makes it possible to pre-position the inflation needle before insertion of the balloon into the patient's stomach. Given the relative dimensioning of this receiving channel and the needle, the latter is immobilized in the pre-positioning configuration in a reliable and stable manner.
• the receiving channel and the needle are shaped and thus adapted to ensure the maintenance of the needle before it is engaged in the septum. As the pre-positioning of the needle is performed without engagement of the needle in the septum, no deterioration of the latter is likely to occur.
• the intragastric balloon can be stored for long periods in this condition without risk for the septum to "keep in memory” the shape of the needle and therefore to see its tightness affected.
• the septum is constituted by a thickness of a material which is not traversed by the needle as long as the balloon is stored before use, it has excellent sealing characteristics by being self-supporting. closing.
• the implementation of an inflation channel avoids any risk of perforation of the flexible envelope of the balloon by the inflation needle.
• the inflation needle is not engaged in the septum of the inflation valve during storage of the balloon so as to preserve its integrity before the implementation of the balloon.
• the needle is then engaged in the septum just before introduction of the balloon in the patient's stomach.
• the inside diameter of the inflation channel may be greater than the outside diameter of the needle.
• the implementation of an inflation channel widened with respect to the diameter of the needle prevents the inflation channel from offering resistance to the engagement of the needle.
• the elongate core may be made of various types of elastomers, preferably synthetic so as to minimize the risk of allergy to the patient.
• the elongate core may be made of biocompatible silicone.
• the inflation valve comprises a body of polymer material inside which extends the elongated core and which is attached to the balloon envelope.
• the body of the valve may then be made of a material of the same nature as the material constituting the flexible envelope or in a material having optimum compatibility with the flexible envelope for assembly by welding or gluing.
• the valve may comprise a preload ring surrounding at least part of the region of the core forming the septum.
• a prestressing ring can then surround only the elongated core or the assembly formed by the body and the elongated core.
• the implementation of such a ring allows the centripetal stresses it applies to the core to increase the capacity of the part of the core forming the septum to close after withdrawal of the inflation needle, which corresponds to the self-closing character of the septum.
• the preload ring is made of a rigid radiopaque material.
• a radiopaque material makes it possible, as its name indicates, to facilitate the identification of the intragastric balloon in the digestive system of a patient by X-ray radiography.
• the prestressing ring can then, for example, be made of metal preferably, but not necessarily non-magnetic, to avoid interactions with the magnetic fields of magnetic resonance imaging medical equipment.
• the preload ring may also be made of thermoplastic material loaded with opaque radio material, such as BaSO4.
• the flexible envelope of the intragastric balloon may be made of any suitable material having suitable airtightness characteristics and dietary or physiological liquids and resistance to acidity of the gastric juices.
• the flexible envelope may, for example but not necessarily, be made from one or more single-layer polyurethane sheets of thickness between 0.1 mm and 0.4 mm.
• the flexible envelope may be constituted by the assembly of sheets of flexible material of different shapes, such as substantially triangular or lenticular, juxtaposed.
• the envelope may also be formed by two discs of the same diameter, assembled edge to edge.
• the assembly of the precut sheets constituting the core can be achieved by any means or appropriate method, such as for example gluing or high frequency welding.
• the latter may be associated with means facilitating and / or controlling this implementation.
• Different corresponding embodiments are specified in claims 11 to 17.
• FIG. 1 is a schematic section of an intragastric balloon belonging to an assembly according to the invention
• FIG. 2 and 3 are longitudinal sections on a larger scale of the balloon inflation valve illustrated in Figure 1 and show two stages of the implementation of the inflation valve with an inflation needle belonging to the assembly according to the invention;
• FIG. 4 is a diagrammatic section of the intragastric balloon as illustrated in FIG. 1, folded inside an endoscope cap belonging to an assembly according to the invention;
• FIG. 5 is a schematic longitudinal section of another embodiment of an assembly according to the invention.
• FIG. 6 and 7 are schematic longitudinal sections, two phases of use, another embodiment of an assembly according to the invention.
• An intragastric balloon according to the invention as illustrated in FIG. 1 and generally designated by reference numeral 1, comprises a flexible envelope 2 made of a material that is impervious to air and to food or physiological liquids.
• the envelope 2 is made by assembling two disks 3 and 4 of monolayer polyurethane, with a thickness e of between 0.1 mm and 0.4 mm and for example, but not exclusively, of the order of 200 microns.
• the two disks are assembled edge to edge by means of a peripheral weld 5.
• the value of the outer radius of the disks will be chosen so that the nominal volume of the inflated balloon 1 is preferably between 400 cm 3 and 800 cm 3 .
• balloons having a nominal capacity of 500 cm 3 and other balloons having a nominal capacity of 700 cm 3 may, for example, be provided for balloons having a nominal capacity of 500 cm 3 and other balloons having a nominal capacity of 700 cm 3 , the size of the balloon used being chosen according to the dimensions of the stomach of the patient or obesity of the latter.
• a balloon that will be inflated to have a nominal volume of 500 cm 3 it may for example be used two discs 7 cm in diameter while to make a balloon that will be inflated so as to have a nominal volume of 700 cm 3 , it can for example be used two discs 11 cm in diameter.
• the casing 2 formed by the assembly of the discs 3 and 4 is preferably rolled up through an opening 6 made in the upper disc 3 for the introduction of an inflation valve 10.
• the rollback of the envelope 2 then allows the peripheral weld 6 to be inside the balloon 1, so that the latter offers a smooth outer surface, thereby reducing the risk of irritation of the gastric wall after implantation.
• the inflation valve 1 0 comprises an elongated core 11 made of elastomer, and in this case, medical silicone.
• the core 1 1 then has an end 12 located outside the balloon and opposite an end 13 located inside the balloon.
• the core 11 is further surrounded by a body 14 made of a polymer material compatible with the material constituting the flexible envelope 2.
• the body 14 is made of polyurethane and has at one end oriented towards the outer end 12 of the core, a weld flange 15 on the upper disk 3.
• the body 14 and the elongate core 11 have complementary conformations so as to immobilize the core 11 in translation relative to the body 14 while ensuring a perfect seal of their contact zone.
• the core 11 extends along an axis ⁇ with a symmetry of revolution relative to the latter.
• the elongated core 11 further comprises a channel 17 for receiving an inflation needle.
• the receiving channel 17 is open at the outer end 12 and has a substantially cylindrical general shape of revolution axis ⁇ .
• the core 11 comprises, opposite the reception channel 17, an inflation channel 18 open at the inner end 13.
• the inflation channel 18 is coaxial with the receiving channel 17 and has a generally cylindrical shape of revolution of axis ⁇ .
• the core 11 then comprises, between the reception channel 17 and the inflation channel 18, a septum 19 which separates the reception channel 17 from the inflating channel 18 in a sealed manner.
• the valve 10 also comprises a ring 20 surrounding both the body 14 and the core 11 on at least part of the septum 19, so as to apply to the latter a centripetal constraint to promote its self-character -obturant, as will appear later.
• the intragastric balloon 1 equipped with such an inflation valve 10 is more particularly intended to be used in association with an inflation needle 25, as illustrated in FIG. 2.
• This needle 25 may for example comprise a tip 26 adapter on a catheter or inflation tube not shown.
• the needle 25 can also be directly adapted to the end of an inflation tube.
• the needle 25 is, according to the example, constituted by a metal tube whose free end will preferably be of foam so as to avoid damaging the valve 10 during the introduction of the needle.
• the needle 25 has a useful length Lu and an outside diameter D e .
• the core 11 then has a length L strictly greater than the effective length Lu of the needle 25, as shown in FIG. 3.
• the latter has an inner diameter di, less than or equal to the outer diameter D e of the needle.
• the inner diameter di of the receiving channel will be chosen to ensure a tight fit with the needle 25 and thus prevent the accidental disengagement of the latter when it is just inserted into the receiving channel 17.
• the receiving channel 17 may be chosen to have a length greater than 1 mm and for example between 1 mm and 8 mm. According to the illustrated example, the reception channel 17 has a length of between 2 mm and 6 mm.
• the inflation lumen 18 will preferably have a diameter d 2 larger than the outside diameter D e.
• the distance D separating the outer end 12 of the core and the inner face of the septum 19 located at the level of the inflation channel 18 will be chosen to be less than the effective length Lu of the inflation needle. It should be noted that, given the value chosen for the length L of the core relative to the useful length Lu of the needle, the end of the latter is inside the inflation channel 18 even when the The needle is completely depressed and thus avoids any risk of deterioration of the envelope 2 of the balloon by the free end of the needle 25. Furthermore, it should be noted that during removal of the needle, the septum closes. naturally, this self-sealing being favored by the stress exerted by the ring 20, which may be, according to the illustrated example, stainless steel preferably non-magnetic.
• the intragastric balloon 1, as so constituted, can be placed in different ways in the stomach of a patient by a professional or operator.
• the balloon can, for example, be lowered inside the stomach by natural ways, directly without any particular accessory.
• the introduction of the balloon can also be ensured by means of an insertion device formed by an endoscope cap 30 as illustrated in FIG. 4.
• the intragastric balloon 1 is folded back to the end. inside a chamber 31 of the cap 30 for an endoscope.
• the chamber 31 has a generally cylindrical shape and is open at a distal opening 32.
• the endoscope cap 30 further comprises a tubular collar 33 for fitting on a not shown endoscope.
• the tubular collar 33 opens into the receiving chamber 31 opposite the distal opening 32.
• the intragastric balloon is then folded inside the chamber 31 so that the outer end 12 of the inflation 10 is located opposite an inflation opening 34 arranged on the upper part of the chamber 31 next to the collar
• the inflation opening 34 provides access to the valve 10 and allows pre-positioning of the inflation needle 25 in the receiving channel 17.
• the operator Before implantation, the operator will take care to completely engage the needle in the valve 10, connect the needle to an inflation tube if this is not the case and then place the cap 30 at the end of an endoscope. The operator then introduces the whole into the patient's stomach via the esophagus. Once, with the hood and the end of the endoscope fitted inside the stomach, the operator inflates the balloon, which will help expel him from the reception room.
• the inflation of the flask may be effected by means of any suitable fluid, such as, for example, a biocompatible gas such as nitrogen or medical carbon dioxide or else air.
• the inflation fluid may also be a biocompatible liquid such as for example water, edible oil or physiological saline. Inflation can also be achieved by means of gas and liquid.
• the gas used may be air and the physiological saline liquid or a food oil optionally supplemented with a biocompatible dye removable kidney such as methylene blue.
• a biocompatible dye removable kidney such as methylene blue.
• a biocompatible dye will easily detect a perforation or accidental leakage of the balloon by staining the urine of the patient.
• it may be provided in association with the intragastric balloon one or more syringes pre-filled with the volume of liquid to be used.
• it may be filled with a volume of liquid representing between 5% and 20% of the nominal volume of the balloon.
• the operator may be provided with a syringe pre-filled with 70 cm 3 of a mixture of physiological saline and methylene blue.
• Other embodiments of inflation are given at the end of the present description.
• Inflation of the balloon is then performed as follows.
• the operator first injects the contents of the pre-filled syringe into the balloon via the inflation tube.
• the operator then completes the filling of the flask by successive injections of fluid air using the same syringe or another syringe.
• the inflation tube may be equipped with a three-way valve, one of which is connected to the inflation tube, another to a tube in the open air possibly equipped with a check valve allowing suction and the last channel is connected to the syringe of filling.
• the operator controls at each injection the volume of air introduced into the balloon and makes as many injections as necessary to reach the intragastric balloon 1 its nominal volume.
• FIG. 5 illustrates another form of introduction device associated with the intragastric balloon according to the invention.
• This oesophageal introduction device generally designated by the reference 40, comprises an introduction tube 41 of elongate shape at least partly flexible.
• the tube 41 has a proximal end 42 and opposite it, a distal end 43.
• the length L 41 of the introduction tube 41 is then chosen so that when the distal end 43 is located inside the the stomach of a patient, the proximal end 42 is on the outside so as to allow maneuver and maintenance by the operator.
• the length L 4 i will, for example, be chosen to be between 47 cm and 70 cm, being for example of the order of 50 cm.
• the introduction tube 41 further has at its distal end 43, a tubular chamber 44 for receiving the intragastric balloon 1 in a folded state.
• the receiving chamber 44 has an enlarged diameter relative to the rest of the introduction tube 41.
• the intragastric balloon 1 is disposed in the chamber 44 so that the outer end of the valve 10 is directed towards the proximal end 42 of the introduction tube 41.
• the introduction device 40 then comprises an inflation tube 45, which is at least partly flexible and which is arranged inside the introduction tube so as to be able to move in translation.
• the distal end 56 of the inflation tube 45 is equipped with the inflation needle 25.
• the gastric balloon 1 and its introduction device 40 have provided the physician with a ready-to-use state as illustrated in Figure 5.
• the balloon operator will push the tube 45 inside the tube 42 so as to engage the needle 25 completely in the valve being understood that the end of the needle 25 will remain confined inside the inflation channel 18 as shown in Figure 3. Then the operator passes the introduction device through the mouth of the patient's pharynx and esophagus, until the distal end of the device in the stomach of the patient.
• the operator ensures a relative translation of the introduction tubes 41 and inflation 45, either by keeping the insertion tube 41 stationary and pushing the inflation tube 45, or by keeping the tube stationary. inflating 45 and pulling the introduction tube 41.
• the outside diameter of the inflation tube may be chosen to be substantially equal to the sliding clearance close to the inside diameter of the introduction tube 41. It may also be envisaged a lubrication with a food oil or a biocompatible silicone oil.
• the proximal portions of the introduction tubes 41 and inflation 45 may be rigid over a certain portion.
• the proximal portion of the inflation tube may be rigid over a portion greater than the length corresponding to the stroke of displacement of the inflation tube in the introduction tube 42.
• L 45 will be greater than or equal to the length L 41 , overall of the introduction tube 41.
• the length L 45 may be between 50 cm and 100 cm and for example to be of the order of 57 cm. It should also be noted that the conformation adopted for the inflation valve and more particularly for its elongated core makes it possible to exert the expulsion effort at the same time. level of the valve, the needle being engaged without risk of perforation of the envelope of the intragastric balloon.
• the chamber 44 is closed, at the disc end 43, by elastically deformable flaps which limit the abrasion of the esophagus during the introduction of the tube 45.
• a removable cap made of a biocompatible material capable of dissolving in the gastric juices and therefore d to be eliminated naturally.
• Such a cap which facilitates the passage into the esophagus can then be released without any risk, during the extraction of the balloon 1 out of the chamber 45, in the patient's stomach.
• This plug may be made for example of a starch-based food material for example.
• the over-tube having an inside diameter adapted to allow easy passage of the introduction device.
• the over-tube would then be put in place at the beginning of the operation during the first control performed with an endoscope just before the introduction of the balloon 2. After removal of the endoscope, the over-tube remained in place is used to passing the introduction device 40.
• the on-tube allows easy passage for inspection by means of the endoscope of the state and the position of the balloon filled in the patient's stomach.
• the over-tube may have a or several lateral openings in its region intended to be at the level of the connection of the larynx to the pharynx.
• a flange 49 softening the surface of the fixing region of the valve 10 on the balloon.
• This flange 49 shown in phantom in FIG. 1, can then be reported or be an integral part of the core 11.
• the insertion device comprises, as has been described with reference to FIG. endoscope cap 30 which has a body 30i defining the chamber 31 open at a distal end 32.
• the body 30i also defines a fitting collar 33 on an endoscope.
• the cap 30 further comprises an elongated flexible guide tube 50, a distal end 51 of which is integral with the body 30 and opens out into the chamber 31.
• the guide tube 50 then has a length sufficient for, when the cap 30 is inside the patient's stomach, that the proximal end of the guide tube 50 is outside the patient through the mouth of the latter.
• the cap 30 further comprises an inflation tube 52 at least in part flexible.
• the inflation tube 52 has a length greater than that of the guide tube 50 and is disposed inside the latter being movable in longitudinal translation.
• the inflation tube 52 is provided at a distal end 53 of the inflation needle 25.
• the introducer further comprises a tubular sleeve 55 open at both its proximal 56 and distal ends 57.
• the sleeve tubular 55 is then adapted to be fitted on the cap 30 at its distal end 32 as will appear later.
• the tubular sleeve 55 further comprises an elongate guide 56, the distal end 57 of which is attached to the sleeve 55.
• the guide 56 then has a length sufficient for when the sleeve 55 is inside the patient's stomach, that the proximal end, not shown, of the guide 56 is located outside the patient through the mouth of the latter.
• the latter comprises a longitudinal core 58, disposed inside a sleeve 57 of flexible plastic material.
• the blade 58 may be made of any suitable material such as for example metal in the form of a torroned cable or a single-strand cable, such as piano wire or the like, made of stainless steel.
• the intragastric balloon 1 is then folded inside the sleeve 55, the valve 10 being located on the side of the proximal end 56 of the sleeve 55.
• the balloon and its introduction device thus constituted are then delivered to the operator in a state as illustrated in FIG. 6, the free end of the needle being engaged in the channel for introducing the valve. without being pressed into the septum of the latter.
• the balloon 1 and its introduction device can then be kept in this blistered state for a long time without risk of altering the properties of the valve 10.
• the operator When the operator wishes to proceed with the introduction of the balloon, he fully depresses the needle 25 in the valve 10, so as to pass through the septum. This insertion is done by hand, the operator holding in one hand the sleeve-balloon assembly and in the other, the distal end 53 of the inflation tube 52. Then, the operator fits the sleeve 55 on the distal end 52 of the cap 30, so as to place the device in a configuration as illustrated in Figure 7. The cap 30 can then be placed at the free end of an endoscope E, the guide 56 and the guide tube 50 being then placed so as to extend along the endoscope E.
• cap assembly 30, sleeve 55, balloon 1 and endoscope E are found in a substantially similar configuration to that described in connection with FIG. 4 and the introduction of the balloon can then be performed, as has been done previously described in relation to this same figure.
• FIGS. 8 and 9 show an alternative embodiment relating to an intragastric balloon 101 and to an associated inflation needle 125.
• the balloon 101 comprises an envelope 102, similar to the envelope 2 of the balloon 1 described above, and an inflation valve 110 sealingly attached to the envelope 102.
• the core 111 of the valve 110 comprises, on the one hand, a channel 117 for receiving the needle 125, open at its outer end 112 and, on the other hand, a coaxial inflation channel 118, open at the level of its inner end 113, while a septum 119 separates the receiving channel 117 from the inflation channel 118.
• the core 111 is surrounded by a body 114 made of compatible polymer material with the material constituting the casing 102, this body 114 being itself surrounded, on at least part of the septum 119, with a prestressing ring 120.
• the valve 110 differs from the valve 10 in two aspects, which can also be implemented independently of one another.
• the receiving channel 117 does not have, like the channel 17, a constant cross section over its entire length, but is provided, at a point of its longitudinal dimension, with a coaxial annular groove 117i.
• this groove 117i is hollowed into the thickness of the core 111 from the surface defining the channel 117, to form a recessed relief.
• the longitudinal extent of the groove 111 ⁇ is limited compared to the total length of the channel 117, so that the presence of this groove does not affect the channel capacity 117 to hold in place the needle 125 when the latter is engaged in this channel without being engaged in the septum 119, as shown in Figure 8.
• the conformational considerations, including dimensional, presented above in that it relates to the channels 17 and 18 and the needle 25 apply to the channels 117 and 118 and the needle 125 to ensure a reliable and stable pre-positioning of the needle 125 in the receiving channel 117, before the operator acts on this needle to engage in the septum 1 19 prior to the introduction of the balloon 101 in the stomach of a patient.
• FIG. 9 illustrates the configuration of the balloon 101 and the needle 125 after the latter has been engaged to the maximum in the septum 119. More precisely, in this configuration shown in Figure 9, the proximal end 125i of the needle 125 is located substantially at the outer end 1 12 of the valve 1 10 so that, as explained in detail above, the free distal end 1252 of the The acute is located inside the inflation channel 118. In this configuration, a projecting annular flange 1253, provided in the running part of the needle 125, near its proximal end 125i, is snapped or, more generally, mechanical engagement in the groove 'I Wi of the receiving channel 117.
• This positional lock between the valve 1 10 and the needle 125 ensures that, once the operator has fully engaged the needle through the septum 119, this needle is gradually withdrawn from the septum, in particular during subsequent manipulations of the assembly to place the balloon 101 in the stomach of a patient. Subsequently, once this balloon 101 is thus put in place and is at least partially filled with fluid as explained above, the needle 125 is disengaged from the valve 1 10, with the application of a pulling force sufficient to remove the flange 125 3 of the groove 117i, the application of this traction force being easily achieved by the operator.
• the proximal end 125i of the needle 125 is provided with stop notches 125 4 shaped to anchor firmly in the distal end of an inflation tube, such as the tube 45 or the tube 52 described above, respectively with respect to FIG. 5 and FIGS. 6 and 7. More precisely, having regard to the shape of these notches 125 4 , their stopping action is significantly stronger in the direction indicated by FIG. arrow F in Figure 9, that is to say in the direction corresponding to a pull on the aforementioned inflation tube to disengage the needle 125 vis-à-vis the valve 110.
• the septum 1 19 is not made available, before engagement therein of the needle 125, in the form of a thickness of non-perforated material, as for the septum 19, but the septum 119 is traversed by a conduit 119i coaxially connecting the receiving channel 117 and the inflating channel 1 1 8. This condu it through 1 1 9i is extremely end compared to the channels 117 and 118, which is why it is shown in dashed lines in Figure 8.
• the transverse fineness of the conduit 1 19i is such that under the pressure of the body 1 14 and , especially, the preload ring 120, this conduit 119i is closed on itself sealingly, which explains why, in practice, it is almost invisible to the eye within the valve 1 10.
• this conduit through 1 19i has the advantage of constituting, in a way, a pre-tro u guiding the distal free end 125 2 of the needle 125 during the depression of the latter through the septum.
• the progression of the needle 125 is facilitated during its insertion through the septum 1 19, thanks to the progressive separation of the conduit 119i under the action of the distal end of the needle, advantageously shaped into the material constituting the septum 119 is thus deformed effectively, limiting the risk of being damaged, for example, by tearing, which ensures, after disengagement of the needle 125 vis-à-vis with respect to the valve 110, the sealed self-sealing of the septum 119.
• the balloon 101 and the needle 125 are used as described above for the balloon 1 and the needle 25, in particular in association with the endoscope cap 30, the guide tubes 50 and inflation tubes 52 and / or the introduction tubes 41 and inflation tubes 45.
• liquid mentioned above is, for example, a sterile saline solution or physiological saline.

Landscapes

• Health & Medical Sciences (AREA)
• Child & Adolescent Psychology (AREA)
• Obesity (AREA)
• Nursing (AREA)
• Orthopedic Medicine & Surgery (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Heart & Thoracic Surgery (AREA)
• Vascular Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• Surgical Instruments (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=40940672

Family Applications (1)

Country Status (4)

Families Citing this family (45)

Family Cites Families (7)

• 2009
  • 2009-02-04 FR FR0950689A patent/FR2941617B1/fr active Active
  • 2009-11-19 WO PCT/FR2009/052227 patent/WO2010089468A1/fr active Application Filing
  • 2009-11-19 EP EP09795472A patent/EP2400933A1/de not_active Withdrawn
  • 2009-11-19 US US13/147,531 patent/US20110295300A1/en not_active Abandoned

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events